Infliximab (intravitreal, 2.0mg/0.05ml)

DRUG2 trials

Sponsors

Icahn School of Medicine at Mount Sinai

Conditions

Diabetic Macular EdemaIntraocular InflammationUveitic Macular Edema

Phase 1

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema

WithdrawnNCT00958906

Icahn School of Medicine at Mount SinaiIntraocular Inflammation, Uveitic Macular Edema

Start: 2009-08-31End: 2009-10-31Target: 10Updated: 2011-06-23

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema

Icahn School of Medicine at Mount SinaiDiabetic Macular Edema

Start: 2009-08-31End: 2011-08-31Target: 10Updated: 2009-08-17